Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by ValueHunter92on Mar 31, 2016 12:31pm
85 Views
Post# 24715684

Huge opportunity for 200-300%

Huge opportunity for 200-300%

Hi there,

Just suggesting to consider BCT  - bria cell.

FDA approved for testing on select other cancers for HER-2 positive patients, increasing BriaCell’s target market five-fold

As previously mentionned, when FDA gives OK for theses kinds of side alternative, it's means severals steps been confirmed and reached, and it's 1 step away from pre-commercialisation.

EX retired FDA's administrator confirmed me tho.
 

Thus said, every investor gotta understand that a lot of pharmaceutical and medical players will accumulate in order to anticipate a positive pre-commercialisation news.

It's going to be big, I'm holding for 35 000$ shares and I'l sells around 100 000$ quite early this month.

Finally, FDA approving for others cancers confirms substainability of initial BriaVax, we are just waiting for a major to take over and this goes

1$ + PPS very reachable intra-days, hopefully more but 75cents + would defenetly satisfy's me

Regards,

Dr Shreiber


Bullboard Posts